Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by MediPharm Labs Corp.

MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF ROMJ TSX-V:ROMJ.V TSX:LABS
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF ROMJF TSX-V:ROMJ.V TSX:LABS
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.